Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

PURPOSE: NCCTG (North Central Cancer Treatment Group) N9831 is the only randomized phase III trial evaluating trastuzumab added sequentially or used concurrently with chemotherapy in resected stages I to III invasive human epidermal growth factor receptor 2–positive breast cancer. PATIENTS AND METHO...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Perez, Edith A., Suman, Vera J., Davidson, Nancy E., Gralow, Julie R., Kaufman, Peter A., Visscher, Daniel W., Chen, Beiyun, Ingle, James N., Dakhil, Shaker R., Zujewski, JoAnne, Moreno-Aspitia, Alvaro, Pisansky, Thomas M., Jenkins, Robert B.
格式: Artigo
語言:Inglês
出版: American Society of Clinical Oncology 2011
主題:
Original Reports
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236650/
https://ncbi.nlm.nih.gov/pubmed/22042958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.36.7045
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍